CVS Health Corporation (CVS) Income Quarterly - Discounting Cash Flows
CVS
CVS Health Corporation
CVS (NYSE)
Period Ending: LTM
(Last Twelve Months)
2025 (Q4)
12-31
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
2013 (Q4)
12-31
2013 (Q3)
09-30
2013 (Q2)
06-30
2013 (Q1)
03-31
2012 (Q4)
12-31
2012 (Q3)
09-30
2012 (Q2)
06-30
2012 (Q1)
03-31
2011 (Q4)
12-31
2011 (Q3)
09-30
2011 (Q2)
06-30
2011 (Q1)
03-31
2010 (Q4)
12-31
2010 (Q3)
09-30
2010 (Q2)
06-30
2010 (Q1)
03-31
2009 (Q4)
12-31
2009 (Q3)
09-30
2009 (Q2)
06-30
2009 (Q1)
03-31
2008 (Q4)
12-31
2008 (Q3)
09-27
2008 (Q2)
06-28
2008 (Q1)
03-29
2007 (Q4)
12-31
2007 (Q3)
09-29
2007 (Q2)
06-30
2007 (Q1)
03-31
2006 (Q4)
12-31
2006 (Q3)
09-30
2006 (Q2)
07-01
2006 (Q1)
04-01
2005 (Q4)
12-31
2005 (Q3)
10-01
2005 (Q2)
07-02
2005 (Q1)
04-02
2004 (Q4)
12-31
2004 (Q3)
10-02
2004 (Q2)
07-03
2004 (Q1)
04-03
2003 (Q4)
12-31
2003 (Q3)
09-27
2003 (Q2)
06-28
2003 (Q1)
03-29
2002 (Q4)
12-31
2002 (Q3)
09-28
2002 (Q2)
06-29
2002 (Q1)
03-30
2001 (Q4)
12-31
2001 (Q3)
09-29
2001 (Q2)
06-30
2001 (Q1)
03-31
2000 (Q4)
12-31
2000 (Q3)
09-30
2000 (Q2)
07-01
2000 (Q1)
04-01
1999 (Q4)
12-31
1999 (Q3)
09-25
1999 (Q2)
06-26
1999 (Q1)
03-27
1998 (Q4)
12-31
1998 (Q3)
09-26
1998 (Q2)
06-27
1998 (Q1)
03-28
1997 (Q4)
12-31
1997 (Q3)
09-27
1997 (Q2)
06-28
1997 (Q1)
03-29
1996 (Q4)
12-31
1996 (Q3)
09-28
1996 (Q2)
06-29
1996 (Q1)
03-31
1995 (Q4)
12-31
1995 (Q3)
09-30
1995 (Q2)
07-01
1995 (Q1)
04-01
1994 (Q4)
12-31
1994 (Q3)
10-01
1994 (Q2)
06-30
1994 (Q1)
03-31
1993 (Q4)
12-31
1993 (Q3)
09-30
1993 (Q2)
06-30
1993 (Q1)
03-31
1992 (Q4)
12-31
1992 (Q3)
09-30
1992 (Q2)
06-30
1992 (Q1)
03-31
1991 (Q4)
12-31
1991 (Q3)
09-30
1991 (Q2)
06-30
1991 (Q1)
03-31
1990 (Q4)
12-31
1990 (Q3)
09-30
1990 (Q2)
06-30
1990 (Q1)
03-31
1989 (Q4)
12-31
1989 (Q3)
09-30
1989 (Q2)
06-30
1989 (Q1)
03-31
1988 (Q4)
12-31
1988 (Q3)
09-30
1988 (Q2)
06-30
1988 (Q1)
03-31
1987 (Q4)
12-31
1987 (Q3)
09-30
1987 (Q2)
06-30
1987 (Q1)
03-31
1986 (Q4)
12-31
1986 (Q3)
09-30
1986 (Q2)
06-30
1986 (Q1)
03-31
1985 (Q4)
12-31
1985 (Q3)
09-30
Report Filing 2026-02-10 2026-02-10 2025-10-29 2025-07-31 2025-05-01 2025-02-12 2024-11-06
1234
Revenue 402,067 105,693 102,871 98,915 94,588 97,710 95,428
1234
Cost of Revenue 346,705 92,126 89,065 85,322 80,192 84,811 82,870
1234
Gross Profit 55,362 13,567 13,806 13,593 14,396 12,899 12,558
1234
Operating Expenses 50,702 11,455 17,013 11,212 11,022 10,531 11,726
1234
Research & Development 0 0 0 0 0 0 0
1234
Selling, General and Administrative 0 0 0 0 0 0 0
1234
Other Operating Expenses 50,702 11,455 17,013 11,212 11,022 10,531 11,726
1234
Operating Income 4,660 2,112 -3,207 2,381 3,374 2,368 832
1234
Net Non-Operating Interest -3,119 -787 -784 -763 -785 -758 -752
1234
Interest Income 0 0 0 0 0 0 0
1234
Interest Expense 3,119 787 784 763 785 758 752
1234
Equity & Other Income/(Expense) 595 29 509 29 28 516 25
1234
Income Before Tax 2,136 1,354 -3,482 1,647 2,617 2,126 105
1234
Income Tax Expense 408 -1,569 508 634 835 503 34
1234
Income Attributable to Non-Controlling Interest -40 -20 -15 -8 3 -21 -16
1234
Net Income 1,768 2,943 -3,975 1,021 1,779 1,644 87
1234
Depreciation and Amortization 4,606 1,147 1,134 1,171 1,154 1,147 1,161
1234
EBITDA 9,266 3,259 -2,073 3,552 4,528 3,515 1,993
1234
Earnings Per Share (EPS) 1.41 2.32 -3.13 0.81 1.41 1.31 0.069
1234
Diluted Earnings Per Share 1.38 2.3 -3.13 0.8 1.41 1.3 0.069
1234
Weighted Average Shares Outstanding 1,270 1,270 1,269 1,266 1,261 1,259 1,259
1234
Diluted Weighted Average Shares Outstanding 1,277 1,277 1,269 1,270 1,264 1,261 1,259
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program